This inventor holds 3 USPTO granted patents. Top assignees: Epoch Biosciences, Inc., Elitech Holding B.v.. Active years: 2007-2010.
Company Filing History:
Years Active: 2007-2010
Title: David Milesi: Innovator in Nucleic Acid Detection and Amplification
Introduction
David Milesi is a notable inventor based in Seattle, WA (US), recognized for his contributions to the field of nucleic acid detection and amplification. He holds a total of 3 patents, showcasing his innovative approach to genetic research and diagnostics.
Latest Patents
Among his latest patents is the "Abasic site endonuclease assay," which presents a novel method for the detection and/or genotyping of nucleic acids. This invention utilizes the specificity of an AP endonuclease, providing a significant advancement in the field. Another important patent is the "Method for amplifying target nucleic acid sequences using a primer comprising an AP endonuclease-cleavable linker." This method involves contacting a sample with specific primers and an AP endonuclease, allowing for the amplification of target nucleic acid sequences in a highly efficient manner.
Career Highlights
David has worked with several companies throughout his career, including Epoch Biosciences, Inc. and Elitech Holding B.V. His experience in these organizations has contributed to his expertise in nucleic acid technologies and innovations.
Collaborations
David has collaborated with notable individuals in his field, including Igor V Kutyavin and Merl F Hoekstra. These partnerships have likely enhanced his research and development efforts.
Conclusion
David Milesi's work in nucleic acid detection and amplification has made a significant impact in the field of genetic research. His innovative patents and collaborations reflect his dedication to advancing scientific knowledge and technology.